Lee's Pharmaceutical posts results of Phase 3 ciprofloxacin-fluocinolone otic solution trial
The study enrolled 600 participants and was completed in October 2021. It evaluated the efficacy and safety of ciprofloxacin 0.3% plus fluocinolone acetonide 0.025% otic solution versus ciprofloxacin 0.3% alone in acute otitis externa.
Primary source
ClinicalTrials.gov results record, October 13, 2026
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Otic Solution in the Treatment of Acute Otitis Externa
Read the source: Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Otic Solution in the Treatment of Acute Otitis Externa clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation